RNA, U6 small nuclear 1134, pseudogene (RNU6-1134P)

RNA, U6 small nuclear 1134, pseudogene (RNU6-1134P) is a genomic locus annotated as a processed pseudogene of a U6 small nuclear RNA (snRNA) gene[1][4][7]. U6 snRNAs are essential components of the spliceosome involved in pre-mRNA splicing in eukaryotes[5][3], but pseudogenes derived from them, including RNU6-1134P, are non-functional copies generated through retrotransposition mechanisms and do not encode a functional RNA product nor participate in splicing or other known biological processes[7][1]. This locus is not considered a receptor, enzyme, transporter, or therapeutic target and should not be treated as such. The “pseudogene” status indicates it lacks a biological or therapeutic function, and there are no known drugs, disease biomarkers, or clinical implications associated with this sequence[1][6][7]. Key details: - RNU6-1134P is only one of many U6 snRNA-derived pseudogenes present in the human genome, which are considered evolutionary byproducts ("genomic fossils") generated mainly via LINE-1-mediated retrotransposition[7]. - While U6 snRNAs are highly conserved and crucial for the spliceosome, pseudogenes themselves play no direct biological or therapeutic role[5][7]. - The only functional U6 RNA is the expressed, mature small nuclear RNA itself; pseudogenes such as RNU6-1134P should not be mistakenly used as drug targets or biomarkers[1][7]. Summary of assessment: RNU6-1134P is not a valid drug or therapeutic target, is not associated with molecular function, clinical utility, or pharmacology, and is functionally distinct from its progenitor U6 snRNA gene. Its presence in annotation sets indicates the need for careful curation when identifying therapeutic targets, as pseudogenes like this are often misclassified in automated pipelines[1][4][7].

Other names

RNU6-1134PU6 small nuclear RNA 1134 pseudogene